ArticleScientific reports2024

Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease.

Lars Tatenhorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.